European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

Jan 11 2016

Today, Janssen-Cilag International NV announced that for the first time, European clinicians in six countries will meet to view and discuss broadcasts of the latest scientific research presented at the 2016 Genitourinary Cancers Symposium, co-sponsored by ASCO^®. New for the 2016 symposium, the Janssen supported event, ASCO DIRECT^TM LIVE, will allow healthcare professionals located in Europe and the Middle East to access new data presentations on genitourinary cancers broadcasted from the symposium.

"ASCO DIRECT^TM LIVE is a 21^st century approach to sharing new scientific data and knowledge amongst healthcare professionals. Busy clinics and local regulations mean that travelling to international conferences has become a rarity for many of my colleagues, so ASCO DIRECT^TM LIVE offers a convenient, alternative way to participate in the symposium," said Professor Kurt Miller, Urologist, Charité Berlin, Germany. "I am looking forward to interacting with my peers in Germany and attendees at the Genitourinary Cancers Symposium in the United States as well as hearing about the latest research in genitourinary cancer care. I encourage other scientific conferences to hold similar initiatives to ensure we can continue to facilitate clinicians’ access to new clinical data in real-time," he continued.

The 2016 Genitourinary Cancers Symposium will take place between 7^th-9^th January 2016 in San Francisco, USA. The program includes sessions on localised and advanced disease, immunotherapy, healthcare outcomes, and challenging cases in common and rare genitourinary tumour types. Through ASCO DIRECT^TM LIVE, simultaneous meetings will be held in Austria, Belgium, Germany, The Netherlands, Switzerland and the United Arab Emirates and include video broadcasts of data presentations and real-time connection with experts onsite.

Jane Griffiths, Company Group Chairman, Janssen Europe, Middle East and Africa (EMEA) said:

ASCO DIRECT^TM LIVE enables the potential for online technology to connect clinicians from different countries. We are pleased to help facilitate this service and provide clinicians with a new avenue to view and discuss vital oncology research. It is our aim to drive greater learning and collaboration amongst international clinicians, which we hope will ultimately lead to improved outcomes and quality of life for genitourinary cancer patients across EMEA.

ASCO DIRECT^TM LIVE 2016 is organised by ASCO^® and Quadia Online Video and supported by Janssen Pharmaceutica NV.